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Visual Abstract
Mutations in the superoxide dismutase 1 (SOD1)
gene contribute to motoneuron degeneration
and are evident in 20% of familial amyotrophic
lateral sclerosis cases. Mutant SOD1 induces
microglial activation through a stimulation of Toll-
like receptors 2 and 4 (TLR2 and TLR4). In the
present study, we identified the proapoptotic
Bcl-2 family protein Bid as a positive regulator of
mutant SOD1-induced TLR-nuclear factor-B
(NF-B) signaling in microglia. bid-deficient pri-
mary mouse microglia showed reduced NF-B
signaling in response to TLR4 activation or ex-
posure to conditioned medium derived from
SOD1G93A expressing NSC-34 cells. Attenuation
of NF-B signaling in bid-deficient microglia was
associated with lower levels of phosphorylated
IKK/ and p65, with a delayed degradation of
IB and enhanced degradation of Peli1. Up-
Significance Statement
Recent work suggests that many proapoptotic proteins also function in other cell-signaling pathways and
may affect inflammatory responses. Inflammation is a hallmark of Amyotrophic Lateral Sclerosis (ALS)
disease models, and inflammation-associated markers in ALS patients are associated with more severe
disease progression. Here we demonstrate that the proapoptotic Bcl-2 family protein Bid plays a crucial role
in mutant SOD1-induced microglial activation, and delineate a novel signal transduction pathway activated
by Bid involving K63-linked polyubiquitination of the E3 ubiquitin ligase tumor necrosis factor receptor
associated factor 6 (TRAF6) and subsequent NF-B activation.
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stream of IKK, we found that Bid interacted with, and promoted, the K63-linked polyubiquitination of the E3
ubiquitin ligase tumor necrosis factor receptor associated factor 6 (TRAF6) in microglia. Our study suggests a key
role for Bid in the regulation of TLR4-NF-B proinflammatory signaling during mutant SOD1-induced disease
pathology.
Bid promotes TLR4-NF-B signaling by interacting with TRAF6 and promoting TRAF6 K63-linked polyubiquiti-
nation in microglia.
Key words: microglia; NF-B; SOD1G93A protein; TLR; Toll-like receptor 4
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal, progres-
sive neurodegenerative disease, characterized by the
selective death of upper motoneurons in the cerebral
cortex and lower motoneurons in the brainstem and
anterior horn of the spinal cord (Ferraiuolo et al., 2011).
Mutations in the superoxide dismutase 1 (SOD1) gene,
linked to chromosome 21q22.1, account for 12–20%
of the familial cases of ALS (Rosen et al., 1993; Renton
et al., 2014). The cytotoxicity of mutant SOD1, a 153 aa
cytosolic protein, is mainly described as a toxic gain-
of-function mechanism (Tu et al., 1996). Mutations in
SOD1 lead to protein misfolding and aggregate forma-
tion (Rotunno and Bosco, 2013) and have been shown
to induce endoplasmic reticulum (ER) stress and pro-
teasomal dysfunction, which trigger several stress-
activated disease processes in ALS (Kikuchi et al.,
2006; Kieran et al., 2007). In addition, mutant SOD1G93A
has been shown to have marked misfolding effects on
wild-type SOD1 (Grad et al., 2011). Of note, it has
become increasingly evident that non-cell autonomous
toxicity mechanisms contribute to mutant SOD1-
induced motoneuron degeneration (Liu et al., 2009;
Grad et al., 2011). Activation of both astrocytes and
microglia are implicated in ALS pathogenesis with glial
cell crosstalk contributing to the burden of inflamma-
tion (Hensley et al., 2006; Evans et al., 2013; Brites and
Vaz, 2014). Studies have identified microglia to be phe-
notypically neuroprotective at disease onset, however a
proinflammatory activation state is soon acquired upon
disease progression resulting in a chronic inflammatory
pathology (Liao et al., 2012). Microglia expressing mu-
tant SOD1 display elevated responses to inflammatory
stimuli (Xiao et al., 2007; Sargsyan et al., 2009), and
mutant SOD1G93A secreted from motoneurons activates
microglia and induces neurotoxicity (Zhao et al., 2010).
Accumulating evidence demonstrates that mutant
SOD1 induces increased Toll-like receptor (TLR) ex-
pression in ALS (Liu et al., 2009; Casula et al., 2011).
TLRs are the master regulators of the cellular innate
immune response (Scheffel et al., 2012), and are key
mediators of the initiation and propagation of the in-
flammatory cascade in response to bacterial, viral or
microbial nucleic acids, known as pathogen-
associated-molecular-patterns (Kielian, 2006). TLR ac-
tivation initiates several cascades of intracellular
pathways, one of which leads to NF-B activation.
NF-B is a transcription factor and the major cytoplas-
mic facilitator of inflammatory stimuli. Recent evidence
suggests that SOD1G93A activates the transmembrane
receptors TLR2 and TLR4 in a CD14-dependent man-
ner (Zhao et al, 2010).
Previous studies observed increased levels of the
Bcl-2 family member Bid (BH3-interacting domain
death agonist) in the spinal cords of SOD1G93A trans-
genic mice (Guégan et al., 2002; König et al., 2014). Bid
is involved in the permeabilization of the mitochondrial
outer membrane during death receptor activation,
which leads to apoptosis (Wang et al., 1996). Recent
research has suggested an immunoregulatory role of
Bid (Mayo et al., 2011, Yeretssian et al., 2011; König
et al., 2014). An interaction between Bid and the innate
immune receptor nucleotide-binding and oligomeriza-
tion domain was suggested, however this study did not
demonstrate attenuated LPS-induced inflammation in
the absence of Bid (Yeretssian et al., 2011). Reduced
phagocytic functioning was revealed in bid-deficient
microglia (Mayo et al., 2011), and Bid was shown to
associate with the IKK complex upstream of NF-B,
specifically NEMO in intestinal epithelial cells (Yerets-
sian et al., 2011) and astrocytes (König et al., 2014).
NEMO/IKK is the regulatory subunit of the IKK com-
plex [IKK, IKK, and IKK/NEMO (NF-B essential
modulator)], activation of which is central to NF-B
activation. We therefore set out to investigate the role
of Bid as a positive regulator of mutant SOD1-induced
TLR signaling in microglia, with a focus on Bid promo-
tion of TLR4-NF-B pathway activation.
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Materials and Methods
Chemicals and antibodies
Common chemicals were obtained from Sigma-Aldrich
unless otherwise stated. Antibodies used for Western blot-
ting and immunohistochemistry include rabbit anti-TLR2
(Abcam, ab108998; 1:500), rabbit anti-TLR4 (Santa Cruz
Biotechnology, sc-10741; 1:100), anti-CD11b (Abcam,
ab8878; 1:400), anti-pIKK/ (Cell Signaling Technology,
92465; 1:500), anti-IL-1 (Abcam, ab9722; 1:2000), anti-
TNF (Abcam, ab9635; 1:500), anti-Bid (Enzo Laboratories,
AR-52; 1:1000), anti-Peli1 (Abcam, ab13812; 1:1000), anti-
pp65 (Cell Signaling Technology, 30315; 1:500), anti-IB
(Cell Signaling Technology, 9242; 1:500), anti-COX-II (BD
Biosciences, 610203; 1:200), anti-TRAF6 (Santa Cruz Bio-
technology, sc8409; 1:200), anti--tubulin (Sigma-Aldrich,
T6199, 1:5000), anti--actin (Sigma-Aldrich, A3853; 1:5000),
anti-GAPDH (Abcam, ab8245-100;1:5000).
Cell culture
BV-2 cells, a murine cell line alternative to primary
microglia commonly used to model the neuroinflamma-
tory role of microglia (Henn et al., 2009), were cultured in
RPMI containing 1% penicillin-streptomycin, 2 mM
L-glutamine, and 10% fetal bovine serum. NSC-34 cells
were kindly donated from the Shaw laboratory at the
University of Sheffield, UK (originally generated by Cash-
man et al., 1992), and were cultured in DMEM with 4.5 g/L
glucose, 1% penicillin-streptomycin, 2 mM L-glutamine,
and 10% fetal bovine serum. HEK293 deficient in TLR4
expression and HEK293/hTLR4-MD2-CD14 cells (kindly
donated by Andrew Bowie, Trinity College Dublin, Ireland)
were cultured in RPMI containing 1% penicillin-strep-
tomycin, 2 mM L-glutamine, and 10% fetal bovine serum.
HEK293-TLR4 media was supplemented with Blasticidin
(InvivoGen; 10 g/ml), Normocin (InvivoGen; 100 g/ml),
and Hygromycin B Gold (InvivoGen; 50 g/ml).
Mixed glial-cell culture and microglial isolation
All procedures involving animals were conducted under
a license from the Department of Health and Children, as
well as the Health Products Regulatory authority in Ire-
land. Procedures were reviewed by the Ethics Committee
of the Royal College of Surgeons in Ireland. Mixed glial
cultures were prepared from the cortices of P0–P2 WT
and bid/ mice of mixed sexes on a C57BL/6 back-
ground. bid/ mice were generated in the laboratory of
Dr Andreas Strasser, WEHI, Melbourne, Australia (Kauf-
mann et al., 2007). The cortices were dissected and the
meninges were removed before incubation in Trypsin-
EDTA at 37°C for 10 min. DMEM-F12/L-glutamine (Gibco,
Life Technologies) containing penicillin-streptomycin (1%;
Sigma-Aldrich) and fetal bovine serum (10%; Sigma-
Aldrich) was added to the cortices before trituration and
passage through a 40 m nylon cell strainer (BD Falcon).
The cells were centrifuged at 300 g for 6 min and the
pellet was resuspended in DMEM-F12 containing Pen/
Strep and FBS. The cells were plated at a density of 4
cortices/T75 flask, and treated with M-CSF (10 ng/ml;
R&D Systems), and GM-CSF (20 ng/ml; R&D Systems)
from 1 day post-dissection to promote microglial prolifer-
ation (Suzumura et al., 1990). Microglia were isolated
using the shaking method. The media containing the de-
tached and floating microglia was collected and centri-
fuged at 800 g for 6 min. The pelleted isolated microglia
were resuspended in DMEM-F12 (containing FBS and
Pen/Strep) and plated at a density of 3.5  105 cells/well
in a 6-well plate. The remaining cells were passaged and
cultured in the absence of M-CSF and GM-CSF to obtain
astrocyte cultures.
Mixed primary motoneuron preparation
Mixed primary cultures enriched for motoneurons were
prepared from C57BL/6 murine WT E12 embryos by the
dissection of the ventral horn of the spinal cord and
subsequent purification, as previously described (Se-
bastia` et al., 2009). In brief, the ventral horns were incu-
bated with 0.025% trypsin in Neurobasal media for 10
min, followed by gentle dissociation in the presence of 0.1
mg/ml DNase1. The dissociated motoneurons were cen-
trifuged at 300  g for 3 min and resuspended in com-
plete Neurobasal media supplemented with 2 mM
GlutaMAX, 2% horse serum, 2% B27, GDNF (Promega,
Catalog #2781; 2 ng/ml), CNTF (R&D Systems, Catalog
#557-NT-10; 1 ng/ml), 100 U/ml penicillin and 100 g/ml
streptomycin. The cells were seeded at a density of 0.25
 106 cells/well in a 24-well plate pre-coated with poly-
ornithine and laminin and cultured at 37° C in 5% CO2.
Motoneurons were harvested for Western blotting at 7
DIV.
Generation of SOD1G93A conditioned media
NSC-34 cells were reverse transfected with 5 g/well
CFP or SOD1G93A-CFP plasmid using Lipofectamine 2000
(1:2, DNA–Lipofectamine; Invitrogen) in Opti-MEM (Invit-
rogen) at a density of 4  105 cells/well in a 6-well plate.
After 4 h of incubation with the transfection mix, the cells
were washed once with serum containing DMEM and
incubated overnight in fresh DMEM containing full serum.
The cells were then washed with serum free DMEM and
incubated in the latter for 3 d before conditioned media
was collected and centrifuged at 800  g for 5 min to
remove cellular debris. Conditioned media was stored at
–20°C or concentrated on 10 kDa size exclusion columns
(10K, Amicon Ultra, UFC501096, Millipore) centrifuged at
4°C at 14,000 rpm for 45 min, boiled in Laemmli buffer for
5 min, and ran on an acrylamide gel for quantification of
SOD1 content in the media.
Overexpression of SOD1G93A in microglia
BV-2 cells were transfected using electroporation
(Amaxa Nucleofector II, Lonza). Briefly, the cells were
harvested and a density of 5 106 cells/5 g plasmid was
used for each cuvette. The cells were washed with RPMI
(centrifuged at 90  g for 10 min) and the pellet was
resuspended in 100 l RPMI including 5 g pcDNA3-CFP
(13030; Addgene), pcDNA-SOD1wt-CFP, or pcDNA-
SOD1G93A-CFP and transfected via electroporation (pro-
gram “A-023”). The transfected cells were carefully
triturated in 1 ml of RPMI and placed in the incubator for
1 min before being plated on 6-well plates. Cells were
incubated for 8 h and lysed using Buffer RLT (Qiagen RNA
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easy kit) for mRNA extraction, or at 24 h in RIPA buffer for
protein analysis. Primary microglia were transfected with
CFP or SOD1G93A-CFP (0.35  106 cells/5 g plasmid)
using Lipofectamine (2 l/g plasmid) and OptiMEM. The
cells were incubated with the transfection mix for 2.5 h
before being replaced with serum containing media. The
cells were lysed in RLT buffer 24 h post-transfection for
RNA extraction and qPCR analysis.
qPCR analysis
RNA was extracted using Qiagen RNAeasy kit and
cDNA was synthesized using random primers and Super-
script RTII (Invitrogen). qPCR analysis was carried out on
a Roche Lightcycler 2.0 using SYBRgreen (Quantitect
SYBRgreen kit, Qiagen). Two microliters of each cDNA
sample and 18 l of the appropriate Mastermix [1 l 10
M primer (forward and reverse), 10 l SYBRgreen PCR
Mix, 7 l RNase-free H20] was added to give a total
volume of 20 l per capillary tube. gapdh was used as an
internal control for each sample analyzed. The cycle pa-
rameters were 95°C for 15 min, 94°C for 15 s, 57°C for 25
s, 72°C for 30 s, and the annealing temperature for each
primer was 57°C. The primers used were as follows:
gapdh (mouse) forward 5= AACTTTGGCATTGTGGAAGG
3=, reverse 5= ACACATTGGGGGTAGGAACA 3=; tlr2
(mouse) forward 5= GCGGACTGTTTCCTTCTGAC 3=, re-
verse 5= CCAAAGAGCTCGTAGCATCC 3=; tlr4 (mouse)
forward 5= GCATGGCTTACACCACCTCT 3=, reverse 5=
GTCTCCACAGCCACCAGATT 3=. Primers were designed
using Primer3 (http://biotools.umassmed.edu/bioapps/
primer3_www.cgi), and are between 150 and 250 base
pairs, optimized for SYBR detection.
Immunohistochemistry
Primary microglia were fixed with 3% paraformalde-
hyde for 12 min at 37°C, washed three times for 5 min in
PBS, and blocked for 30 min at room temperature in
blocking solution [5% horse serum, 0.3% Triton X-100
(Sigma-Aldrich) in PBS]. After three washes with PBS the
primary antibody [anti-CD11b (1:200) or anti-pIKK/ (1:
500)] was diluted in PBS 1% horse serum, 0.3% Triton
X-100 in PBS and added to the wells (150 l/well of
24-well plate), before incubation for 2 h at room temper-
ature. The cells were washed three times with PBS and
incubated in the dark with an AlexaFluor secondary anti-
body solution for 1 h at room temperature (1:500) in 1%
horse serum, 0.3% Triton X-100 in PBS (anti-mouse Al-
exaFluor 488, Invitrogen A10037), anti-rabbit AlexaFluor
488 (Invitrogen, A21441), anti-rat AlexaFluor488 (Invitro-
gen, A11006), anti-mouse AlexaFluor 568 (Invitrogen,
A10037), anti-rabbit AlexaFluor 568 (Invitrogen). Hoechst
was used as a nuclear stain (Hoechst 33342, Invitrogen).
Mean fluorescence was analyzed using ImageJ (NIH; im-
agej.nih.gov/ij).
Co-immunoprecipitation and pull-down experiments
Overexpression of tumor necrosis factor receptor asso-
ciated factor 6 (TRAF6) was performed by transfection of
the pCMV5-FLAG-wt-TRAF6 vector in BV-2 cells. In
short, BV-2 cells were transfected with FLAG-wt-TRAF6
(Addgene, 21624) or pCMV5-FLAG (1.5 g/3  105 cells)
using Lipofectamine. The cells were stimulated with LPS
for 1 or 4 h (1 g/ml BV-2, or 100 ng/ml primary glia and
astrocytes). Cells were lysed in RIPA buffer (Tris 50 mM,
NaCl 150 mM, SDS 0.1%, sodium-deoxycholate 0.5%,
Triton X-100 or NP-40 1%, plus 1:100 Protease Inhibitor,
Sigma-Aldrich). Co-immunoprecipitation or pull down ex-
periments were performed using DynaBeads Protein G
[35 l of Dynabeads/sample (100–400 g protein), Life
Technologies, 10007D], and a magnetic rack (Life Tech-
nologies). The beads were washed in RIPA buffer and
incubated with 5 g primary antibody (in 200 l PBS for
30 min at room temperature). The beads were washed
three times for 5 min in RIPA buffer and equal amounts of
protein (100 g) were incubated rotating for 2 h at room
temperature (in a total volume of 750 l). The protein was
eluted from the beads and denatured in RIPA buffer plus
1 Laemmli buffer by incubating for 10 min at 70°C. The
tubes were placed on the magnetic rack and the dena-
tured supernatant was collected for gel electrophoresis.
siRNA transfection
An siRNA targeting Bid, sequence ACACGACUGU-
CAACUUUAU, was designed using an algorithm opti-
mized for siRNA selection (Reynolds et al., 2004), and
obtained from Sigma-Aldrich. Briefly, BV-2 cells were
transfected with 100 M siRNA/3  105 cells using Lipo-
fectamine. Optimal silencing of bid was determined by
qPCR analysis to be 48 h post-transfection. An siRNA
consisting of a scrambled nucleotide sequence was used
as the control in siRNA experiments.
Western blot
Media was aspirated from the cells and the wells were
washed gently with PBS and lysed with 80 l/well of
6-well plate RIPA buffer for Western blot analysis. The cell
lysates were incubated on ice for 15 min and centrifuged
at 4°C at 13,000 rpm. The supernatants were used to
determine the protein concentration by BCA assay (Micro
BCA protein determination kit, Thermo Scientific). Laem-
mli buffer was added to each sample and the samples
were boiled for 5 min and loaded onto 10%, 12%, or 15%
polyacrylamide gels as appropriate. Semi-dry transfer
was performed on to PVDF membrane for 1.5 h at 18 V.
Membranes were exposed to Ponceau S and blocked in
3% milk for 1 h. Primary antibodies in 3% milk were
incubated either overnight at 4°C or 2 h at room temper-
ature. The membranes were washed in TBS-Tween 20
(0.1%), and placed in 3% blocking solution containing the
appropriate secondary antibody (peroxidase-conjugated
anti-mouse IgG, anti-rabbit IgG, or anti-goat IgG, Sigma-
Aldrich; 1:5000, as appropriate) for 2 h at room tempera-
ture. The membrane was washed three times for 5 min in
TBS-Tween 20, exposed to ECL Chemiluminescent Re-
agent (Millipore) for 5 min and imaged on a LAS-3000
Imager (Fuji). Quantification of protein levels were calcu-
lated from optical density measurements from Western
blot experiments and normalized to respective loading
control (-Tubulin, -actin, or GAPDH).
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Dual-luciferase assay
BV-2 cells were cotransfected by reverse transfection
with renilla and firefly luciferase reporter gene vectors
(renilla luciferase plasmid: firefly luciferase plasmid, 1:12)
in Opti-MEM (Sigma-Aldrich; 1 g plasmid per well/100
l) using X-tremeGENE HP Reagent (Roche; 2 l/g plas-
mid). Following 5 h incubation with transfection mix the
cells were washed and incubated with BV-2 growth media
(RPMI  10% FBS, 1% L-glutamine and 1% Pen/Strep)
overnight. BV-2 cells were treated with 100 M Bid Inhib-
itor (BI-6C9, Sigma-Aldrich), resuspended in DMSO, at a
concentration 100 M 30 min prior to treatment with LPS
(1 g/ml; Sigma-Aldrich, Catalog #L4391). BV-2 cells
were lysed in 1 Passive Lysis Buffer (Promega) and
luminescence was measured using Dual-Luciferase As-
say Kit (Promega). HEK293 and HEK294-TLR4 cells were
similarly cotransfected with constitutive renilla (phRL-TK)
and firefly B-luciferase reporter gene vectors [1:12 in
OptiMEM using Lipofectamine (2 l/1 g plasmid)] by
reverse transfection for 3 h before the cells were allowed
to recover overnight in full serum media. After being
washed gently with serum-free media both HEK293 and
HEK293-TLR4 cells were stimulated with CFP or
SOD1G93A-CFP conditioned media for 8 or 24 h before
being lysed in passive lysis buffer, with luminescence
measured using the method as above.
Proximity ligation assay
The in situ proximity ligation assay (PLA) was carried
out using the Duolink system (DUO92101-1KT, Sigma-
Aldrich). This technique allows the identification of prox-
imity between epitopes of proteins in a complex in vitro by
using hybridization between oligonucleotides linked to
secondary antibodies when bound to primary antibodies
against two specific proteins in close proximity40 nm in
situ (Soderberg et al., 2006). Here we used mouse anti-
TRAF6 (1:100) and rabbit anti-Bid (1:500; Abcam,
ab62469) as primary antibodies to determine close prox-
imity. BV-2 cells were plated in a 96-well plate and trans-
fected with either pCMV-Myc-FLAG or pCMV-FLAG-
TRAF6wt (Plasmid 21624, Addgene) at a concentration
of 0.075 g/2  104 cells. Twenty-four hours post-
transfection the cells were exposed to serum free media 2
h prior to treatment with either vehicle (1 PBS) or LPS (1
g/ml). The cells were immunostained as described
above. Controls included combinations of mouse anti-
TRAF6 (1:100) plus rabbit anti-HA-tag (1:500; Santa Cruz
Biotechnology, sc805), and rabbit anti-Bid plus mouse
anti-IRF2 (1:500; Santa CruzBiotechnology, sc101069).
PLA probes were diluted in primary antibody diluent (1%
horse serum and 0.3% Triton x-100 in PBS) at a ratio of
1:10 and incubated for 1 h at 37°C. The ligation stock was
diluted (1:5) with high-purity H2O and ligase 1:40. Twenty
microliters per well of ligation–ligase solution was incu-
bated with the cells at 37°C for 30 min. The cells were
incubated with the amplification solution (1:5 with high-
purity H2O and 1:40 polymerase) for 100 min at 37°C. The
cells were washed three times with PBS and Hoechst was
used as a nuclear stain (1:1000 in PBS, Hoechst 33342).
The wells were imaged in order to detect amplification
dots representing TRAF6-Bid close-proximities and anal-
ysis was performed using ImageJ software.
Statistical analysis
Statistical analysis was performed using GraphPad
Prism software or MATLAB software (v2014b, Math-
Works) as applicable. Results are represented as mean 
SEM. Statistical significance was determined using the
tests as detailed in the respective figure legends and
Table 1 (p  0.05).
Results
SOD1G93A overexpression increases TLR2 and TLR4
levels and COX-2 activation in microglia
To explore the role of TLRs in SOD1 disease pathology,
we analyzed tlr2 and tlr4 expression in response to over-
expressed SOD1G93A in microglia. BV-2 cells transiently
transfected with mutant SOD1G93A exhibited a significant
increase in tlr2 (Fig. 1A; 2.17-fold  0.84) and tlr4 (Fig.1B;
1.55-fold  0.37) mRNA levels. We also observed in-
creased TLR2 (Fig. 1C,E; 1.6-fold  0.51) and TLR4 (Fig.
1D,F; 1.72-fold  0.37) protein levels in SOD1G93A-
transfected BV-2 cells compared with CFP-control trans-
fected cells, analyzed by Western blotting. These results
suggested that the presence of SOD1G93A primed micro-
glia for increased TLR2 and 4 signaling.
Cyclooxygenase-II (COX-II), an enzyme that is induced in
response to proinflammatory stimuli (Nadjar et al., 2005;
Laflamme et al., 1999), is recognised as a target gene of
NF-B activation (Nakao et al., 2000; Nadjar et al., 2005).
We found significantly increased COX-II levels in re-
sponse to transient transfection of BV-2 cells with
SOD1G93A (Fig. 1G,H; 2.07-fold  1.11 increase), and
following paracrine stimulation with SOD1G93A condi-
tioned media (Fig. 1I,J; 2.1-fold  0.33 increase). COX-II
levels were not significantly induced in TLR2 and TLR4-
inhibited BV-2 cells, using the small molecule inhibitor
OxPAPC, which were stimulated with NSC-34-derived
SOD1G93A-conditioned media (Fig. 1I,J). OxPAPC (1-
palmitoyl-2-arachidonyl-sn-glycero-3-
phosphorylcholine), an oxidized phospholipid, was used
here to selectively inhibit TLR2 and TLR4 dimerization by
interacting with MD2, LPS-binding protein, and CD14, an
extracellular receptor which is indispensable for both
TLR2 and TLR4 dimerization (Fitzgerald et al., 2004; Err-
idge et al., 2008), thus blocking TLR2- and TLR4-induced
activation. Additionally, COX-II levels were significantly
lower in OxPAPC treated cells stimulated with SOD1G93A-
conditioned media compared with control cells exposed
to the same stimulus (Fig. 1I,J; 2.2-fold  0.407 de-
crease), suggesting that SOD1G93A elicited its toxicity
through TLR-NF-B signaling. Next HEK293 cells that are
deficient in TLR4 (Stack and Bowie, 2012) and HEK293
cells stably expressing TLR4 were exploited to demon-
strate the requirement of TLR4 in SOD1G93A-mediated
NF-B activation. HEK293 cells stably expressing TLR4
showed increased NF-B activation, as measured by
NF-B reporter firefly luciferase readout in response to
stimulation in paracrine with SOD1G93A (Fig. 1K; 1.35-fold
 0.31 increase), with no increased NF-B activation
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observed in HEK293 cells devoid of TLR4. These data
support the previous findings by Zhao et al. (2010) and
points toward a TLR4-dependent mechanism of action of
SOD1G93A.
bid/ microglia show reduced NF-B activation
upon TLR4 stimulation
To investigate the involvement of Bid in microglial immune
responses we examined Bid protein levels in resting WT
mixed motoneurons, astrocytes, and microglia. We found
higher levels of Bid protein in astrocytes and microglia
(Fig. 2A,B; astrocytes 5.9-fold  2.78, microglia 6.2-fold
 2.08), verifying previous findings (König et al., 2014). To
investigate the effects of Bid deficiency on SOD1G93A-
induced microglial tlr4 mRNA expression we generated
WT and bid/ primary microglia cultures and transiently
transfected the microglia with CFP or SOD1G93A-CFP. tlr4
expression was higher in SOD1G93A-overexpressing wild-
type microglia compared with bid-deficient microglia (Fig.
2C; 2.9-fold  1.2 increase vs 0.8-fold  0.9 decrease).
tlr4mRNA levels did not significantly increase in wild-type
microglia overexpressing SOD1G93A compared with CFP-
transfected microglia, but increased TLR4 protein levels
were detected in SOD1G93A-overexpressing BV-2 cells
(Fig. 1D,F).
To additionally investigate the effect of a lack of Bid on
TLR4-induced proinflammatory signaling in microglia
both WT and bid/ microglia were stimulated with the
well characterized TLR4 agonist LPS (Takeuchi et al.,
1999). Of note, both TLR2 and TLR4 signal to NF-B via
the MyD88-dependent pathway (Akira and Hoshino,
2003). Wild-type and bid/ microglia were stimulated
with LPS for 4 h and lysed for Western blot analysis of the
cytokine IL-1 and TNF levels. IL-1 was used as a
proinflammatory marker as IL-1 has been shown to be
rapidly secreted in response to LPS (Dinarello, 1997) and
to be critical in the NF-B induction of COX-II-derived
prostaglandins in the CNS (Laflamme et al., 1999). TNF
Table 1. Statistical table
Label Data structure Type of test Significance
Fig. 1A Nonparametric Paired two-tailed t test n  8–10 cultures
p  0.0156
Fig. 1B Nonparametric Paired two-tailed t test n  8–9 cultures
p 0.007
Fig. 1E Nonparametric Paired two-tailed t test n  6 cultures
p 0.031
Fig. 1F Nonparametric Paired two-tailed t test n  6 cultures
p 0.031
Fig. 1H Nonparametric Paired two-tailed t test n  3 cultures
p 0.0106
Fig. 1J Parametric One-way ANOVA, Tukey post-hoc test n  3 cultures
p 0.0021
Fig. 1K Parametric Paired two-tailed t test n  11 wells from 2
separate experiments
p 0.0216 HEKTLR4
cells CFP vs SOD1G93A
Fig. 2C Parametric One-way ANOVA, Bonferroni’s
multiple-comparison test
n  4–6 cultures
p 0.027
Fig. 3C Parametric Three-way ANOVA, Tukey post hoc test n  3 cultures
p 0.0147 WT vs bid
Fig. 3G Parametric One-way ANOVA, Tukey’s
multiple-comparison test





multiple-comparison post hoc test
n  6–16 cultures
DMSO LPS vs DMSO Veh
p  0.0001
BI Veh vs DMSO Veh
p  0.6926
BI LPS vs DMSO Veh
p  0.5933
BI Veh vs DMSO LPS
p  0.0001
BI LPS vs DMSO LPS
p 0.0162
BI LPS vs BI Veh
p  0.0162
Fig. 4B Parametric Three-way ANOVA, Tukey post hoc test n  3 cultures
p  0.000823
WT vs bid
Fig. 5F Nonparametric Kruskal–Wallis, Dunn’s
multiple-comparison post hoc test
p  0.0378
minus LPS vs plus LPS
Fig. 6F Nonparametric Kruskal–Wallis, Dunn’s
multiple-comparison post hoc test
n  3 cultures
p  0.0509
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is a proinflammatory cytokine secreted in response to
LPS (Sawada et al., 1989), and microglial secretion of
TNF is shown to induce motoneuron death in vitro (He
et al., 2002). Analysis revealed substantially reduced pro-
inflammatory cytokine IL-1 and TNF production (Fig.
2D,E) in bid-deficient microglia compared with wild-type
cells 4 h post stimulation with LPS.
Because microglia are the first line of immune response
in CNS pathogenesis we investigated the effect of bid-
deficiency on microglial TLR4-NF-B activation following
acute LPS stimulation. LPS-induced activation of the IKK
complex leads to IB degradation, in a phosphorylation-
induced and proteasome-dependent manner (Alkalay
et al., 1995; Brown et al., 1995; Yang et al., 2003). Wild-
type and bid/ microglia were stimulated with LPS for 5
min, fixed in 3% formaldehyde and stained with anti-
CD11b and anti-pIKK/. CD11b is a cluster of differen-
tiation molecule that is highly expressed in cells of the
innate immune system, including macrophages and mi-
croglia, and is involved in mediating inflammation by reg-
ulating migration and adhesion properties. CD11b was
used as a microglial marker and the fluorescence intensity
of pIKK/ was measured on CD11b-expressing cells.
Overall decreased immunofluorescence of phosphory-
lated IKK/ was noted in LPS-stimulated Bid-deficient
microglia compared to wild-type CD11b-positive cells
(Fig. 3A). Western blot analysis of microglia stimulated
acutely with LPS, for 5, 15, 30, min or 1 h, showed
significantly less phosphorylation of IKK/ and less
phosphorylated p65 in bid/ microglia compared with
WT upon LPS stimulation from 5 min to 1 h (Fig. 3B,C).
The degradation profile of the NF-B inhibitor IB was
measured as an indicator of TLR4-NF-B activation (Fig.
3D,E) and demonstrated that bid-deficiency delayed
signal-induced degradation of IB noted at 30 min and 1






Figure 1. TLR2 and TLR4 expression is increased in response to SOD1G93A overexpression. BV-2 cells were transiently transfected
with CFP or SOD1G93A-CFP plasmids and harvested at 8 or 24 h post-transfection. A, tlr2mRNA expression in transfected BV-2 cells
was measured at 8 h post-transfection by qPCR analysis, relative to control gene gapdh (n  8–10 wells pooled from 3 separate
experiments; Kruskal–Wallis, Dunn’s multiple-comparison post hoc test). B, tlr4 mRNA was analyzed by qPCR analysis of BV-2
lysates 8 h post-transfection with CFP or SOD1G93A-CFP (n  8–9 wells pooled from 2 separate experiments). Samples were
normalized to internal control gapdh. C, E, TLR2 protein levels in CFP or SOD1G93A-CFP-transfected BV-2 cells analyzed by Western
blot. BV-2 cells were lysed in RIPA buffer 24 h post-transfection via nucleofection (normalized to -Tubulin OD, n  6 wells pooled
from 4 separate experiments; p 0.031, two-tailed paired t test). D, F, TLR4 protein levels in CFP or SOD1G93A-CFP-transfected BV-2
cells analyzed by Western blot. BV-2 cells were lysed in RIPA buffer 24 h post-transfection via nucleofection (normalized to -Tubulin
OD n  6 wells pooled from 4 separate experiments; p  0.031, two-tailed paired t test). G, H, COX-II levels were assessed in
SOD1G93A overexpressing BV-2 cells (n  3 cultures from 2 separate platings; p  0.016, two-tailed paired t test). BV-2 cells were
transfected with CFP or SOD1G93A-CFP via electroporation and lysed in RIPA buffer 24 h post-transfection and prepared for Western
blot analysis. I, J, COX-II levels in TLR2- and TLR4 -inhibited BV-2 cells following stimulation with CFP or SOD1G93A cMedia. BV-2
cells were treated with OxPAPC (30 g/ml) simultaneous to cMedia treatment. Cells were lysed 24 h post-cMedia stimulation and
prepared for Western blot analysis (n  3 wells, p  0.002, one-way ANOVA, Tukey’s multiple comparison post hoc test). K, NF-B
activity in TLR4-deficient HEK293 and HEK293-TLR4-stably expressing cells stimulated with SOD1G93A conditioned media. HEK293
and HEK293-TLR4 were cotransfected with B-RE-luciferase and RLTK-Renilla-luciferase for normalization for 24 h and subsequently
stimulated with CFP or SOD1G93A cMedia for 8 or 24 h. The cells were lysed in passive lysis buffer and measured as B-dependent
firefly activity normalized to renilla luciferase activity per well (n  11 wells pooled from 2 separate experiments; p  0.021, two-tailed
paired t test between HEK-TLR4 treated cells). Conditioned media was generated by overexpression of CFP or SOD1G93A-CFP
vectors in NSC-34 cells, with serum-free conditioned media collected 3 d post-transfection.
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et al., 2011). Interestingly there was a delay in recovery of
IB levels at 2 h post LPS stimulation in the bid/
microglia compared with wild-type, suggesting a delay in
the positive feedback response in the absence of bid.
Additionally, the phosphorylation of p65 was significantly
induced in wild-type microglia but not in bid-deficient
microglia 1 h post LPS stimulation (Fig. 3F,G; 3.7-fold 
1.3 increase vs 2.7-fold  0.8 increase).
NF-B transactivation potential, as measured by B-
response element-dependent luciferase expression, was
also significantly reduced when Bid was inhibited using
100 M of the small molecule Bid inhibitor (BI-6C9) prior to
LPS stimulation (24 h) in BV-2 cells (Fig. 3H; BI-6C9 
LPS decreased 3.00  1.858-fold compared with DMSO
 LPS). COX-II levels were assessed in Bid-depleted
BV-2 cells following stimulation in paracrine with
SOD1G93A. BV-2 cells were transfected with siRNA target-
ing Bid followed by stimulation with SOD1G93A in cMedia.
Western blot analysis determined reduced COX-II levels in
SOD1G93A-treated BV-2 cells when Bid was depleted
compared with control siRNA-transfected BV-2 cells ex-
posed to the same SOD1G93A stimulus (Fig. 3I,J; 1.6-fold
 0.8 increase vs 0.8-fold  0.6 decrease).
Reduced levels of Peli1 in bid/ microglia upon
TLR4 activation
A number of E3 ubiquitin ligases regulate NF-B signaling
and activation. Peli1 is responsible for catalyzing the K63-
linked polyubiquitination of the Interleukin-1 receptor-
associated kinase (IRAK) complex (Moynagh, 2009) and
has been described as a key regulator of CNS inflamma-
tory pathogenesis (Song and Qian, 2013). Wild-type and
bid/ microglia were stimulated with LPS acutely as
above, and lysed for Western blot analysis. Overall, Peli1
levels were significantly lower in bid-deficient microglia at
early time-points post LPS stimulation (from 5 min to 1 h
post-treatment) compared with wild-type microglia (Fig.
4A,B; WT microglia 1.49  0.57-fold increased vs 0.59






Figure 2. Bid is highly expressed in microglia, SOD1G93A-overexpressing bid-deficient microglia express reduced tlr4 mRNA levels
compared with wild-type, and levels of proinflammatory IL-1 and TNF are reduced in LPS-stimulated bid/ microglia. A,
Representative Western blot showing Bid levels and (B) quantification of optical density analysis of Bid levels in motoneurons,
astrocytes and microglia. Primary mixed motoneurons were harvested at 7DIV, and purified astrocytes and isolated microglia were
lysed 2 d post-plating to allow time for the cells to become quiescent. Bid protein levels were examined, by Western blot, in purified
astrocytes and microglia at rest compared with motoneurons. Bid protein levels were assessed by measuring the optical densities of
each sample relative to that of the respective loading control (B; GAPDH or -actin, experiment was repeated 3 times with similar
results). C, tlr4 mRNA expression in wild-type and bid/ primary microglia overexpressing CFP or SOD1G93A-CFP, analyzed by
qPCR. Samples were normalized to internal control gapdh (n  4–6 wells pooled from 2 separate experiments; p  0.027, one-way
ANOVA, Bonferroni’s multiple-comparison post hoc test). D, IL-1 levels were analyzed by Western blot in wild-type and bid/
microglia 4 h post-LPS treatment. E, TNF levels were analyzed in wild-type and bid-deficient microglia 4 h post-LPS stimulation.
Wild-type and bid/ microglia were stimulated with vehicle, LPS (100 ng/ml) for 4 h before being harvested with RIPA lysis buffer
and used for Western blot analysis.
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Figure 3. Reduced phosphorylation of IKK/, p65 and delayed IB degradation and reduced NF-B activation in bid/ microglia.
A, Primary wild-type and bid/ microglia were stimulated with LPS for 5–30 min in serum-free media before being fixed in 3%
paraformaldehyde and stained with anti-phosphorylated IKK/ (pIKK/) and anti-CD11b. Immunohistochemistry analysis of
anti-pIKK/ mean fluorescence on CD11b-positive cells is depicted. Scale bar, 50 M. B, C, Primary wild-type and bid/ microglia
were treated with LPS for 5, 15, 30 min, or 1 h in serum-free media before being lysed for Western blot analysis of pIKK/ protein
levels (n  3 pooled from 3 separate experiments; p  0.014, 3-way ANOVA, Tukey post hoc test). D, E, Wild-type and bid/
microglia were stimulated with LPS for 5 min to 2 h in serum-free media, lysed in RIPA buffer and IB levels were analyzed by
Western blot (n  3–4 wells from 3–4 separate experiments). F, G, Wild-type and bid/ microglia were stimulated with LPS for 1 h
before being lysed in RIPA buffer. pp65 levels were assessed by Western blot (n  7 wells pooled from 6 separate experiments; p
 0.0162, one-way ANOVA, Tukey’s post hoc test). H, BV-2 cells were cotransfected with NF-B-RE-luciferase and renilla-luciferase
plasmids for 24 h and subsequently treated with LPS for 24 h. The cells were lysed in passive lysis buffer and NF-B activation was
quantified by dual luciferase assay (represented as relative B-dependent firefly activity, n  6–16 wells pooled from 2 separate
experiments, 2 outliers removed, Grubbs test followed by Kruskal–Wallis and Dunn’s multiple-comparison post hoc test). I, J, COX-II
levels in Bid-depleted BV-2 cells stimulated with CFP or SOD1G93A cMedia. BV-2 cells were transfected with an siRNA targeting Bid
(“siBid”) or a scrambled control siRNA (“siControl”), and stimulated with cMedia 48 h post-siRNA transfection, when Bid levels were
optimally reduced. Twenty-four hours post-cMedia treatment the cells were lysed in RIPA and COX-II levels were measured. Dashed
line indicated irrelevant lanes spliced out. Quantification of optical density was normalized to anti--tubulin for each Western blot
(n  3, from 3 separate experiments).
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Bid promotes TRAF6-mediated polyubiquitination
Previous studies have identified Bid and IKK/NEMO as-
sociation in response to inflammatory stimuli in intestinal
epithelia (Yeretssian et al., 2011), as well as astrocytes.
Here we identified an interaction with an upstream medi-
ator of NEMO activation, TRAF6 (Goh et al., 2012).
TRAF6, a member of the TRAF family of intracellular
signaling adaptor proteins, is critical for K63-linked ubiq-
uitination of both Peli1 and the IRAK complex (Conze
et al., 2008; Goh et al., 2012; Moynagh, 2014). We found
that Bid and TRAF6 coimmunoprecipitated in BV-2 cells
and WT glia (Fig. 5A–C). This interaction between TRAF6
and Bid was additionally investigated in astrocytes by
coimmunoprecipitation. Here we observed that TRAF6
immunoprecipitated with Bid in wild-type astrocytes upon
LPS stimulation for 1 h, an interaction that was not seen in
bid-deficient astrocytes (Fig. 5D). Additionally, we used
proximity-ligation assays to explore the association of Bid
with TRAF6 proteins within microglia in situ. Here, a sig-
nificant increase in Bid and TRAF6 close-proximities was
detected upon LPS stimulation in BV-2 cells (Fig. 5E,F;
1.9-fold increase  1.24).
Ubiquitination is a post-translational modification that
involves the formation of ubiquitin linkage chains and
leads to a variety of biological processes depending on
which of the seven lysine residues of ubiquitin (K6, K11,
K27, K29, K33, K48, K63) are covalently conjugated to
form a polyubiquitin chain (Ikeda and Dikic, 2008). In
addition, recent studies have identified a hybrid K63/linear
(K63/M1)-linked ubiquitin chain formation in IKK complex
signaling and subsequent NF-B activation (Emmerich
et al., 2013). As the polyubiquitination of TRAF6 is essen-
tial for the positive regulation of downstream proteins of
the TLR-NF-B pathway, such as NEMO, TAK1, and Peli1
we next assessed the levels of TRAF6 polyubiquitination
in wild-type glial cells overexpressing Bid (Fig. 6A). Higher
levels of TRAF6 polyubiquitination were present in wild-
type glia compared with bid-deficient cells (Fig. 6A,B;
0.75-fold  0.41 decrease). Overexpression of Bid pro-
moted TRAF6 polyubiquitination in glial cells, however,
basal levels of Bid also showed increased TRAF6 polyu-
biquitination compared with bid-deficient glia (Fig. 6B,D).
In addition, the impact of the absence of Bid on TRAF6
K63-linked autoubiquitination was investigated. Wild-type
and bid/ glial cells overexpressing Bid and/or Ubiquitin-HA
were stimulated with LPS for 1 h and TRAF6 was immuno-
precipitated from these samples. Subsequent Western blot
analysis of immunoprecipitated samples revealed an in-
creased K63-linked polyubiquitination of TRAF6 in LPS stim-
ulated wild-type microglia overexpressing ubiquitin-HA
compared with bid/ glia overexpressing ubiquitin-HA (Fig.
6C,D; 0.67-fold  0.3 decrease). Next, the levels of total
K63-linked ubiquitin chains were assessed in wild-type and
bid-deficient microglia upon acute stimulations with LPS for
30 min and 1 h (Fig. 6E,F; 2.1-fold  0.42 increase vs
1.5-fold  0.36 increase 1 h post-LPS stimulation). The
microglia were lysed and analyzed byWestern blot, using an
anti-K63-linked ubiquitin chain specific antibody. Lower lev-
els of total K63-linked ubiquitin chains were observed when
Bid was absent in microglia.
Discussion
In this study, we demonstrate that Bid positively mediates
microglial TLR4-NF-B signaling, highlighting a nonapo-
ptotic role of Bid in regulating immune responses in the
CNS. Bid promotes the K63-linked polyubiquitination of
TRAF6 upstream of IKK and absence of Bid attenuates
the TLR4-induced NF-B proinflammatory microglial re-
sponse.
There is an emerging emphasis on the role of the innate
immunity in driving neurodegenerative disease progres-
sion (Nguyen et al., 2002; Zhao et al., 2010), with mount-
ing evidence implicating a central role of microglia in ALS
pathogenesis (Beers et al., 2006; Di Giorgio et al., 2007;
Glass et al., 2010). TLR2 and TLR4 mediate ALS-linked
mutant SOD1 toxicity, as extracellular mutant SOD1G93A
activates microglia in a CD14-dependent manner (Zhao
et al., 2010; Lee et al., 2015). Here we show increased
TLR2 and TLR4 levels following overexpression of
SOD1G93A in BV-2 cells. Moreover, the data presented
demonstrates increased COX-II levels in response to
SOD1G93A, elicited through both autocrine and paracrine
stimulation, further consolidating the previous findings
presenting TLR2, TLR4, and NF-B activation in mutant
SOD1 treated microglia (Frakes et al., 2014; Lee et al.,
2015). A lack of induction of Bid in microglia upon mutant
SOD1 or LPS stimulation was observed (data not shown),
indicating that the constitutively high levels of microglial
A B
Figure 4. Peli1 levels are reduced in bid/microglia upon LPS stimulation. A, B, Peli1 levels were analyzed by Western blot analysis
in wild-type and bid/ microglia upon acute LPS stimulation (B; n  3 cultures from 3 separate platings; three-way ANOVA, Tukey’s
multiple-comparison post hoc test). Cells were stimulated with LPS (100 ng/ml) in serum-free media for the relevant treatment time
points, lysed in RIPA buffer and prepared for Western blot analysis.
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Bid are sufficient for the signaling cascade to respond to
TLR4-induced stimulation.
Recent studies proposed that Bid positively regulates
the immunological profile of macrophages and epithelial
cells, and Bid-deficiency resulted in decreased proinflam-
matory cytokine mRNA levels in response to LPS in
microglia (Mayo et al., 2011), and attenuated NF-B acti-
vation in astrocytes (König et al., 2014). These findings are
of critical importance as elevated levels of Bid are seen
both in the spinal cord and activated astrocytes in the
SOD1G93A transgenic mouse model (Guégan et al., 2002;
König et al., 2014), suggesting increased Bid levels may
contribute to the chronic inflammation evident in ALS
disease progression. Interestingly, TNF levels increase
concurrent with disease progression in mutant SOD1-
linked ALS pathogenesis (Hensley et al., 2003), and here
we found reduced levels of TNF in LPS-induced bid-
deficient microglia. We have demonstrated that Bid is
highly expressed in unstimulated microglia, and that mi-







Figure 5. Bid associates with TRAF6 in microglia and astrocytes, as shown by coimmunoprecipitation and PLA. A, Coimmunopre-
cipitation of Bid and TRAF6 in BV-2 cells. BV-2 cells were stimulated with LPS (1 g/ml) for 15 min or 1 h and Bid was
immunoprecipitated. Negative controls included anti-Bid immunoprecipitation from bid-deficient mixed glia lysates, and IgG immu-
noprecipitation from all samples. Cells were lysed in RIPA buffer and analyzed for TRAF6 content after immunoprecipitation of Bid.
B, Coimmunoprecipitation of Bid and TRAF6 in BV-2 cells overexpressing TRAF6-FLAG. BV-2 cells were stimulated with LPS (1
g/ml) and lysed in RIPA buffer. FLAG was detected by Western blotting and represents TRAF6FLAG immunoprecipitated with Bid
in BV-2 cells. An IgG immunoprecipitation was included as a negative control. C, Coimmunoprecipitation of Bid and TRAF6 in WT and
bid-deficient primary mixed glia stimulated with LPS for 1 and 4 h (100 ng/ml). Samples were lysed post-LPS stimulation and Bid was
immunoprecipitated from the lysates. The samples were analyzed for TRAF6 content by Western blotting. IgG immunoprecipitation
was carried out as an additional negative control. D, Coimmunoprecipitation of Bid and TRAF6 in wild-type and bid/ astrocytes.
Purified astrocytes were stimulated with LPS (100 ng/ml) for 1 and 4 h, and lysed in RIPA buffer for Bid immunoprecipitation. The
samples were analyzed for TRAF6 by Western blotting. E, Representative images of PLA and phase contrast in TRAF6-FLAG
overexpressing BV-2 cells immunostained with anti-Bid and anti-TRAF6 (n  2 wells/condition, 4 fields of view per well). Negative
control representative images of PLA in TRAF6-FLAG overexpressing BV-2 cells immunostained with anti-TRAF6 and anti-HA-tag (n
 1 well/condition, 6 fields of view-LPS, 1 field of view  LPS), or immunostained with anti-Bid and anti-IRF2 (n  1 well/condition,
7 fields of view). Scale bar, 10 m. F, Quantification of PLA interactions in BV-2 cells. BV-2 cells were transfected with TRAF6-FLAG
or empty FLAG vector and stimulated with LPS for 1 h. The cells were fixed with 3% paraformaldehyde, incubated with anti-Bid and
anti-TRAF6 and PLA was quantified (significant increase of PLA dots in TRAF6 transfected versus control transfected cells and vehicle
vs LPS treated cells, two-way ANOVA). Negative controls included immunostaining with anti-Bid plus anti-IRF2, and anti-TRAF6 plus
anti-HA-tag.
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icity. The role of microglia in SOD1-mediated toxicity has
been supported by studies which demonstrate that accu-
mulation of mutant SOD1 in either motoneurons alone
(Pramatarova et al., 2001) or astrocytes (Gong et al., 2000)
may not be sufficient to efficiently cause motoneuron
degeneration, with the addition of SOD1G93A microglia to
co-cultures shown to induce motoneuron death (Zhao
et al., 2010). Additionally, a recent study shows that
NF-B is activated concurrently with disease progression
in SOD1G93A mice, and that inhibition of NF-B in micro-
glia rescued motoneurons from cell death in SOD1G93A
murine cells in culture, and delayed motor function defi-
cits in SOD1G93A mice (Frakes et al., 2014).
The therapeutic potential of attenuated TLR4 signalling
in ALS is highlighted in studies demonstrating reduced
motoneuron degeneration in SOD1G93A mice lacking tlr4
(Lee et al., 2015), and in rescued SOD1G93A stimulated
motoneuron death in vitro using TLR4 inhibitors (De Paola
et al., 2016). We demonstrate that Bid has a specific role
in TLR4 signaling, as LPS primarily elicits its response via
TLR4 and is a potent agonist of TLR4-mediated NF-B
activation (Hoshino et al., 1999; Bottcher et al., 2003),
inducing the pro-inflammatory M1 activated microglial
phenotype (Chhor et al., 2013). Acute LPS stimulations
reveal decreased phosphorylation of IKK and IKK, re-
quired for activation of the IKK complex and further sig-
naling to IB (Wang et al., 2001). IB sequesters NF-B
subunits in the cytosol inhibiting their nuclear transloca-
tion, and bid-deficient microglia showed protracted IB
degradation kinetics, indicating delayed TLR4 signaling
(Mayo et al., 2011). Our data demonstrates decreased
NF-B activation levels in Bid-inhibited LPS-stimulated
BV-2 cells. Constitutive activation of NF-B in WT micro-
glia induces both gliosis and motoneuron cell death
(Frakes et al., 2014), and therefore ablating this activation
may ameliorate both of these hallmarks of ALS aetiology,




Figure 6. Bid promotes K63-linked polyubiquitination of TRAF6. A, TRAF6 polyubiquitination levels in wild-type and bid/ glia.
TRAF6 was immunoprecipitated and TRAF6 polyubiquitination was assessed in WT mixed glia overexpressing Bid-dsRed plus
Ubiquitin-HA (HA-Ub), and wild-type glia overexpressing ubiquitin-HA plus dsRed. bid/ glia were transfected with ubiquitin-HA plus
dsRed. Immunoprecipitation of IgG was used as an immunoprecipitation control. Single membrane cut as represented by dashed line.
B, Quantification of TRAF6-linked ubiquitin chains, as measured by OD in wild-type and bid/ glia transfected with ubiquitin-HA plus
dsRed (n  2 pooled from 2 separate experiments). C, Wild-type and bid/ glia were transfected with the following plasmids, Bid
plus dsRed, ubiquitin-HA plus dsRed or Bid plus ubiquitin-HA plasmids for 24 h and subsequently stimulated with LPS for 1 h. The
cells were lysed in RIPA buffer. TRAF6 was immunoprecipitated from the transfected cell lysates and the samples were analyzed by
Western blot. The membrane was exposed to an anti-K63-linked ubiquitin-specific antibody, which identified the K63-linked
ubiquitination of TRAF6. D, Quantification of TRAF6 K63-linked ubiquitin chains, as measured by optical density in wild-type and
bid/ glia transfected with ubiquitin-HA plus dsRed (n 2–3 from 2–3 separate experiments). E, Representative Western blot of total
K63-linked ubiquitination levels in WT and bid-deficient microglia upon LPS stimulation. F, Quantification of OD analyses of total
K63-linked polyubiquitination in wild-type and bid/microglia following LPS stimulation (n 3 cultures from 3 separate experiments;
p  0.050, one-way ANOVA, Dunn’s multiple-comparison post hoc test). Wild-type and bid/ microglia were treated with LPS (100
ng/ml) for 30 min or 1 h before lysis in RIPA buffer and K63-linked ubiquitination levels were analyzed probing with anti-K63-linked
ubiquitin-specific antibodies in Western blotting experiments.
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TLR-NF-B signaling is tightly regulated by a number of
E3 ubiquitin ligase proteins. It has previously been re-
ported that the E3 ubiquitin ligase Peli1 regulates the
NF-B pathway and reduced Peli1 levels are shown to
impair TLR signaling (Jiang et al., 2003). Here we identi-
fied decreased levels of Peli1 upon acute LPS stimulation
in bid/ microglia compared with wild-type. As Peli1
facilitates the K63-linked ubiquitination of the IRAK com-
plex (Butler et al., 2007; Ordureau et al., 2008), and sub-
sequent downstream signaling to NF-B, reduced Peli1
levels in bid-deficient microglia may suggest accelerated
Peli1 degradation. We propose this to be a process by
which Bid regulates TLR-induced NF-B activation.
Many studies to date have shown that the TRAF6 RING
domain is essential for the activation of IKK in TLR sig-
naling by either activation of TAK1 (Lamothe et al., 2007;
Walsh et al., 2008) or the Peli1-IRAK complex (Conze
et al., 2008). Additionally, inhibiting the formation of Peli1-
IRAK-TRAF6 interactions was identified to prevent the
degradation of the NF-B inhibitor IB (Choi et al., 2006).
We propose that an interaction between Bid and the E3
ubiquitin ligase protein TRAF6 modulates the NF-	 sig-
naling pathway in microglia. Together with previous
studies, our data implies a potential cell-type-specific
interaction between Bid and different signaling proteins
essential for NF-B activation. Interestingly the Bid-
TRAF6 interaction we observe in microglia suggests that
Bid may interact specifically with E3 ubiquitin ligase pro-
teins, which regulate NF-B activation. Ubiquitination of
multiple proteins, forming mainly K63 and M1 chains (for
review, see Iwai et al., 2014), is required for NF-B
activation, in order for the IKK complex to become phos-
phorylated with subsequent K48-linked proteasomal deg-
radation of IB, resulting in the release NF-B into the
cytosol. TRAF6 activates NF-B via facilitating the recruit-
ment of the TAK1/TAB1/TAB2 complex (Lamothe et al.,
2007) and by directly forming ubiquitin chains with NEMO
(Gautheron et al., 2010) and IRAK-1 (Qian et al., 2001). We
have demonstrated that Bid promotes the autoubiquitina-
tion of TRAF6, specifically K63-linked ubiquitination upon
LPS stimulation. TRAF6 is autoubiquitinated by K63-
linked chains, preventing the K48-linked degradation of
TRAF6, and providing docking sites for an array of pro-
teins that mediate NF-B activation (Chen, 2005). The
requirement of TRAF6 autoubiquitination for TRAF6-
mediated ubiquitination of target proteins is debatable,
with some studies arguing TRAF6 autoubiquitination to be
unnecessary (Walsh et al., 2008; Wang et al., 2010) and
other studies demonstrating that TRAF6 autoubiquitina-
tion is essential for TRAF6-mediated NEMO K63-ubiqui-
tination and downstream NF-B activation (Lamothe
et al., 2007). Interestingly, it has been reported that unan-
chored polyubiquitin chains generated by TRAF6 can ac-
tivate both TAK1 and IKK complexes (Xia et al., 2009).
Additionally, TLR4 is of increasing interest in ALS ther-
apeutics, with another agonist of TLR4, high-mobility
group box 1 (HMGB1), shown to be secreted from mo-
toneurons and to have increased reactivity in astrocytes
and microglia concurrent with ALS disease progression
(Lo Coco et al., 2007; Lee et al., 2015). Of note, TNF
secretion from NF-B-activated glial cells provides a
death receptor agonist which may contribute to the rate of
motoneuron death (Aebischer et al., 2013). We propose
that the Bid-potentiated polyubiquitination of TRAF6 pos-
itively regulates TLR4-induced NF-B signaling by pro-
moting Peli1-IRAK-TRAF6 interactions and supporting
proinflammatory signal propagation to IB and NF-B.
Furthermore, as NF-B is a complex therapeutic target, a
cell-specific approach may prove more effective. Deple-
tion of microglial Bid offers a potential avenue for the
regulation and attenuation of the TLR4- and TRAF6-
mediated inflammatory response in ALS pathogenesis.
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